Paul Tudor Jones Zoetis Inc. Call Options Transaction History

Tudor Investment Corp Et Al

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$145.54 - $178.83 $1.95 Million - $2.4 Million	13,400 Added 82.72%	29,600 $5.13 Million
Q1 2024 May 15, 2024	BUY	$165.67 - $199.94 $2.22 Million - $2.68 Million	13,400 Added 478.57%	16,200 $2.74 Million
Q4 2023 Feb 14, 2024	BUY	$151.44 - $200.09 $424,032 - $560,252	2,800 New	2,800 $552,000
Q1 2023 May 15, 2023	SELL	$145.48 - $175.02 $494,631 - $595,068	-3,400 Reduced 38.64%	5,400 $899,000
Q4 2022 Feb 14, 2023	BUY	$131.14 - $157.47 $1.15 Million - $1.39 Million	8,800 New	8,800 $1.29 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $1.12 Million - $1.43 Million	5,800 New	5,800 $1.42 Million

1,897

423M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $91.2B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.